Rxsight is up a bit on the day, funds flowing in kept the price up 2.14% since yesterday.
Currently RXST isn't at a clear support/resistance line that seems tradable. Rxsight hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. RXST might find some support at the 13.97 level, buyers might push the price back up from here. But it's not very clear what will happen.